Answers are grounded in this paper and cite their sources.
The progression of MA in patients with neovascular AMD undergoing anti-VEGF treatment differed significantly depending on the subtype of neovascularization. The risk of foveal involvement in MA was associated with the baseline factors or phenotype of neovascular AMD rather than with injection frequency of anti-VEGF.
No takes yet. Share an insight, caveat, or question.
Cho et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: